I agree this is gonna be great. Remember Hemaxellerate is an orphan drug for Aplastic Anemia. So the huge move up will be big! Orphan drug biotechs tend to go up higher than other biotechs that only fight cancer and other diseases.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.